Browse by author
Lookup NU author(s): Dr Bridget Wilkins
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
We report a new variant of the BCL1 syngeneic mouse B-cell lymphoma model, which we have called pi-BCL1. pi-BCL1 can be established as a syngeneic tumor in BALB/c mice. Tumors can be removed, prepared and easily grown in liquid culture and subsequently transferred back successfully as syngeneic tumors. As a syngeneic tumor pi-BCL1 behave more like a lymphoma with solid tumor masses, than a chronic lymphocytic leukaemia of the original BCL1 model. The immunophenotype and the growth characteristics of the pi-BCL1 and BCL1 tumors appear very similar. Cytologically, pi-BCL1 appears to be a transformation from a small lymphocytic lymphoma to a more diffuse large cell centroblast-like higher-grade lymphoma. We are not aware of any previous reports of such transformation events in a syngeneic animal model of B cell lymphoma. We believe pi-BCL1 provides a useful new tool for the study of B cell lymphoma in vitro and in vivo and enables reduced numbers of tumor passage in mice.
Author(s): Illidge T, Honeychurch J, Howatt W, Ross F, Wilkins BS, Cragg M
Publication type: Article
Publication status: Published
Journal: Cancer Biotherapy & Radiopharmaceuticals
Year: 2000
Volume: 15
Issue: 6
Pages: 571-580
ISSN (print): 1084-9785
ISSN (electronic): 1557-8852
Publisher: Mary Ann Liebert, Inc. Publishers
URL: http://dx.doi.org/10.1089/cbr.2000.15.571
DOI: 10.1089/cbr.2000.15.571
Altmetrics provided by Altmetric
